Kiran Patel

Kiran Patel

Johnson & Johnson Co. - New Jersey / United States
Medical and Health Sciences / Medical Oncology
AD Scientific Index ID: 4399768
-
person_outline Kiran Patel's MOST POPULAR ARTICLES
1-) Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UKM Voysey, SAC Clemens, SA Madhi, LY Weckx, PM Folegatti, PK Aley, ...The Lancet 397 (10269), 99-111, 202140752021
2-) Combined BRAF and MEK inhibition in melanoma with BRAF V600 mutationsKT Flaherty, JR Infante, A Daud, R Gonzalez, RF Kefford, J Sosman, ...New England Journal of Medicine 367 (18), 1694-1703, 201228732012
3-) Improved survival with MEK inhibition in BRAF-mutated melanomaKT Flaherty, C Robert, P Hersey, P Nathan, C Garbe, M Milhem, ...New England Journal of Medicine 367 (2), 107-114, 201223792012
4-) Combined BRAF and MEK inhibition versus BRAF inhibition alone in melanomaGV Long, D Stroyakovskiy, H Gogas, E Levchenko, F de Braud, J Larkin, ...New England Journal of Medicine 371 (20), 1877-1888, 201421162014
5-) Mortality and pulmonary complications in patients undergoing surgery with perioperative SARS-CoV-2 infection: an international cohort studyD Nepogodiev, A Bhangu, JC Glasbey, E Li, OM Omar, JFF Simoes, ...The Lancet 396 (10243), 27-38, 202018952020